Dr. Arroyo is a tenured pharmaceutical executive who has deep expertise in strategy, and leading the clinical development of therapeutics across multiple disease areas. He is currently the Chief Development Officer of Bicycle Therapeutics. Prior to joining Bicycle, Dr. Arroyo held the Chief Medical Officer position at Momenta Pharmaceuticals leading the company’s clinical development programs until Momenta’s acquisition by Johnson & Johnson. Previously, he was the Chief Medical Officer of Boston Pharmaceuticals and before that held multiple senior clinical development leadership roles at leading pharmaceutical companies including Pfizer, Inc., Bristol-Myers Squibb, Eisai Global Clinical Development and Schwarz Biosciences.
Dr. Arroyo was an Instructor at the Johns Hopkins Medical School, Associate Professor at the Medical College of Wisconsin and Senior Specialist at the Hospital Clinic of Barcelona. He earned a Ph.D. from the Universidad de Barcelona and an M.D. from the Universidad Autonóma de Madrid. Dr. Arroyo is also a non-executive director of Lundbeck.